Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria de Navarra (8)

2024

  1. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  2. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

2023

  1. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2020

  1. Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation

    Nutrients, Vol. 11, Núm. 2

  2. Comparison of correlations of equation-derived body fat percentage and body mass index with carotid intima-media thickness

    Acta Diabetologica, Vol. 56, Núm. 3, pp. 373-375

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

2017

  1. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome

    Scientific Reports, Vol. 7, Núm. 1